Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

OBJECTIVE: This study was conducted to explore the application of age-male-ALBI-platelets (aMAP) score for predicting late recurrence of hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA) and develop an aMAP score based-nomogram to predict prognosis in Chinese population. MATERIA...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Hepatocell Carcinoma
Päätekijät: Yang, Yi, Zhou, Yanzhao, Zhang, Xinyuan, Xin, Yujing, Chen, Yi, Fan, Qingsheng, Li, Xiao, Wei, Xi, Li, Qiang, Zhou, Xiang, Zhou, Jinxue
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327363/
https://ncbi.nlm.nih.gov/pubmed/34350139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S308587
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia